Catalyst Wire Dossier Catalyst Wire Dossier

Oxomemazine, guaifenesin, and potassium iodate combination

· EMS
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oxomemazine, guaifenesin, and potassium iodate combination, covering 2019-04-17 to 2019-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Comparison Between Oxomemazine, Guaifenesin and Potassium Iodate Versus Guaifenesin Monotherapy in Acute Cough Treatment [Phase 3]

See pricing